Related Experiment Videos
Claudio Jommi1, Patrizio Armeni1, Arianna Bertolani1
1Cergas, Centro di Ricerche sulla Gestione dell'Assistenza Sanitaria e Sociale, SDA Bocconi School of Management, Università Bocconi, Milano - Italy.
Global & Regional Health Technology Assessment
|January 11, 2023
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Phase I clinical trials for cardiovascular diseases in Europe: analysis of trends, distribution, and regulatory context.
Frontiers in pharmacology·2026
Same author
Assessment and Appraisal of Drug Innovativeness in Italy: Ultimate Evidence on Key Drivers and Consistency.
Journal of market access & health policy·2026
Same author
In Hospital Assessment and Management of High Bleeding Risk in Patients with ST-Elevation Myocardial Infarction (STEMI).
Journal of cardiovascular development and disease·2026
Same author
Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differences.
European heart journal·2026
Same author
More and earlier data from AIFA: do they impact on the regional policies? Results from an exploratory analysis.
Global & regional health technology assessment·2026
Same author
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study.
Advances in therapy·2026
Same journal
Impact of AIFA Note 100 on innovative antidiabetic prescribing eligibility in two Italian local health authorities: drug utilization and patient characteristics.
Global & regional health technology assessment·2026
Same journal
Impact of Ministerial Decree 77/2022 from different stakeholders' perspectives: clinicians, pharmacists, patients, and industry.
Global & regional health technology assessment·2026
Same journal
Comments on: Italian Medicines Agency's reform and time until pricing and reimbursement decisions: a time-to-event analysis.
Global & regional health technology assessment·2026
Same journal
Author's reply to comments to: Italian Medicines Agency's reform and time until pricing and reimbursement decisions: a time-to-event analysis.
Global & regional health technology assessment·2026
Same journal
Procedural activity and dynamics of the new Italian Scientific and Economic Committee (CSE): a one-year observational analysis.
Global & regional health technology assessment·2026
Same journal
Optimizing CAR-T therapy delivery in the Italian healthcare system: economic and organizational insights in follicular lymphoma.
Global & regional health technology assessment·2026